Bariatric surgery as urate-lowering therapy in severe obesity
The emerging problem of biological treatment in migrant and travelling populations
Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes
Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis
The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis
Ustekinumab for the treatment of patients with active ankylosing spondylitis
Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis
Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials
Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort
Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies
What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review
Safety profile of protein kinase inhibitors in rheumatoid arthritis
The relationship between longitudinal serum leptin measures and measures of magnetic resonance imaging-assessed knee joint damage in a population of mid-life women
Genetics of toll like receptor 9 in ANCA associated vasculitides
Development of patient-centred standards of care for rheumatoid arthritis in Europe
Development of healthcare quality indicators for rheumatoid arthritis in Europe
Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy
Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers
Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice—a translational model for atherosclerosis
Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis
Testing the role of vitamin D in response to antitumour necrosis factor α therapy in a UK cohort
Fibrosis biomarkers in isolated Raynaud's phenomenon
Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients
Use of statins is associated with a lower prevalence of generalised osteoarthritis
Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab
Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour
When is it not ethical to withhold treatment for rheumatoid arthritis?
Response to
The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis
Response to
Are autoantibodies to RNA-polymerase III to be incorporated in routine diagnostic laboratory algorithms for systemic autoimmune rheumatic diseases?
Response to